16 Papers
19 Citations
Yiming Chen is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Lenalidomide & Transplantation. The author has an hindex of 13, co-authored 16 publications.
Chat about Author
Papers
Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma
Paolo Strati,Ankur Varma,Sherry Adkins,Loretta J. Nastoupil,Jason R. Westin,Fredrick B. Hagemeister,Nathan Fowler,Hun J. Lee,Luis Fayad,Felipe Samaniego,Sairah Ahmed,Yiming Chen,Sandra B. Horowitz,Sara Arafat,Swapna Johncy,Partow Kebriaei,Victor E. Mulanovich,Ella Ariza Heredia,Sattva S. Neelapu +18 more
TL;DR: The results suggest the need for prolonged monitoring and prophylaxis against opportunistic infections in these patients, to improve the longterm safety of axicabtagene ciloleucel therapy.
Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study.
Haijun Wang,Yiming Chen,Fanglin Li,Kay Delasalle,Jialei Wang,Raymond Alexanian,Larry W. Kwak,Luis O. Rustveld,Xianglin L. Du,Michael Wang +9 more
TL;DR: Waldenstrom macroglobulinemia (WM) is a non‐Hodgkin lymphoma (NHL) subtype and little is known about the incidence and trends for this disease in the United States.
120
Acute Promyelocytic Leukemia: A Population-Based Study on Incidence and Survival in the United States, 1975 – 2008
TL;DR: A population‐based study of APL in the United States to determine its incidence and relative survival during a 34‐year period.
Persistence of Cytogenetic Abnormalities at Complete Remission After Induction in Patients With Acute Myeloid Leukemia: Prognostic Significance and the Potential Role of Allogeneic Stem-Cell Transplantation
Yiming Chen,Jorge E. Cortes,Zeev Estrov,Stefan Faderl,Wei Qiao,Lynne V. Abruzzo,Guillermo Garcia-Manero,Sherry Pierce,Xuelin Huang,Partow Kebriaei,Tapan M. Kadia,Marcos de Lima,Hagop M. Kantarjian,Farhad Ravandi +13 more
TL;DR: Persistent cytogenetically abnormal cells at CR predict a significantly shorter RFS and OS, and SCT in CR1 may improve the clinical outcome of patients lacking cytogenetic remission after induction although this depends on patient selection.
Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study
M. Kay Garcia,Lorenzo Cohen,Ying Guo,Yuhong Zhou,Bing You,Joseph S. Chiang,Robert Z. Orlowski,Donna M. Weber,Jatin P. Shah,Raymond Alexanian,Sheeba K. Thomas,Jorge E. Romaguera,Liang Zhang,Maria Badillo,Yiming Chen,Qi Wei,Richard T. Lee,Kay Delasalle,Vivian Green,Michael Wang +19 more
TL;DR: Acupuncture may help patients experiencing thalidomide- or bortezomib-induced peripheral neuropathy in cancer patients with multiple myeloma, and larger, randomized, clinical trials are needed.